Wei Xiao
Fortuna: 32 M $ al 31/08/2026
Fortuna: 32 M $ al 31/08/2026
Wei Xiao is the founder of Jiangsu Kanion Group Co., Ltd., founded in 1999, holding the title of Secretary since 1999.
Dr. Xiao currently holds the position of Chairman at Kangyuan Huawei Pharmaceutical Co., Ltd. since 2021.
Dr. Xiao also holds the position of Director at Jiangsu Kanion Pharmaceutical Co., Ltd. since 2025.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/04/2026 | 17.023.232 ( 2,95 % ) | 32 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JIANGSU KANION PHARMACEUTICAL CO.,LTD. | Director/Miembro de la Junta | 20/06/2025 |
Jiangsu Kanion Group Co., Ltd.
Jiangsu Kanion Group Co., Ltd. Financial ConglomeratesFinance Provides investment services | Fundador | 01/01/1999 |
Kangyuan Huawei Pharmaceutical Co., Ltd.
Kangyuan Huawei Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Presidente | 04/03/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Kanion Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes Chinese pharmaceutical products | Health Technology |
Jiangsu Kanion Group Co., Ltd.
Jiangsu Kanion Group Co., Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Kangyuan Huawei Pharmaceutical Co., Ltd.
Kangyuan Huawei Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.